We therefore determined the mRNA level of the following targets: hENT1, dCK, PN-I, CDA, dCMPD, CTP synthetase and RR (subunit 1 and 2) in leukaemic blasts from children with newly diagnosed AML. The gene discussed is SLC29A1; the disease is acute myeloid leukemia.